(Press-News.org) Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a leading cause of cancer-related deaths worldwide. While environmental and genetic factors contribute to HCC, increasing evidence points to epigenetic dysregulation as a central driver in hepatocarcinogenesis. This review article published in eGastroenterology systematically explores the epigenetic mechanisms implicated in HCC pathogenesis, providing a comprehensive view of how these alterations contribute to tumor initiation, progression, and resistance to therapy.
DNA methylation, particularly the addition of a methyl group to the 5’ position of cytosine within CpG islands, plays a critical role in gene expression regulation. In HCC, aberrant DNA methylation contributes to both the silencing of tumor suppressor genes and the activation of oncogenes:
(1) Hypermethylation of Tumor Suppressors: Genes such as CDKN2A, RASSF1A, and SOCS1 are frequently hypermethylated in HCC, leading to loss of function in pathways regulating cell cycle and apoptosis.
(2) Global Hypomethylation: This phenomenon affects genome stability and may activate transposable elements and oncogenes.
The article emphasizes that these methylation changes can occur early during hepatocarcinogenesis, making them promising biomarkers for early detection.
Histone proteins undergo post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination, which collectively regulate chromatin structure and gene expression:
(1) Histone Acetylation/Deacetylation: Histone acetyltransferases (HATs) and histone deacetylases (HDACs) are frequently deregulated in HCC. Overexpression of HDACs leads to chromatin condensation and gene silencing of tumor suppressors.
(2) Histone Methylation: Aberrant histone methylation is also implicated. The review highlights that histone methyltransferases like EZH2 are often upregulated in HCC, contributing to transcriptional repression of genes involved in tumor suppression.
These alterations reinforce the malignant phenotype and influence therapeutic responsiveness.
Noncoding RNAs (ncRNAs), including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), have emerged as key players in HCC pathogenesis:
(1) MicroRNAs: Dysregulation of miRNAs such as miR-122, miR-221, and miR-21 modulates signaling pathways including Wnt/β-catenin, PI3K/Akt, and TGF-β, which are crucial in liver cancer progression.
(2) Long Noncoding RNAs: LncRNAs like HULC, MALAT1, and HOTAIR are overexpressed in HCC and act as oncogenic drivers by sponging tumor-suppressive miRNAs or interacting with chromatin modifiers.
(3) Circular RNAs: CircRNAs contribute to miRNA sponging and are involved in the regulation of cell proliferation and metastasis.
Importantly, these ncRNAs not only act as regulators but also hold potential as biomarkers for diagnosis and prognosis.
The review underscores the interplay between different epigenetic modifications in HCC. For example, ncRNAs can influence DNA methylation and histone modifications, while histone modifiers can regulate the transcription of ncRNA genes. This interconnected network amplifies the oncogenic effects of epigenetic dysregulation and may explain the heterogeneity and aggressiveness of HCC, making them candidates for noninvasive biomarkers and therapeutics:
(1) DNA Methylation Panels: Circulating methylated DNA fragments can serve as early indicators of HCC.
(2) ncRNA Profiles: Plasma levels of specific miRNAs and lncRNAs correlate with tumor stage, metastasis, and patient survival.
(3) DNMT Inhibitors: Agents like 5-azacytidine and decitabine restore tumor suppressor expression by demethylating DNA.
(4) HDAC Inhibitors: Vorinostat and belinostat show promise in reactivating silenced genes and enhancing sensitivity to immunotherapy and chemotherapy.
(5) Targeting ncRNAs: Antisense oligonucleotides and miRNA mimics are being developed to modulate the function of oncogenic or tumor-suppressive ncRNAs.
However, challenges remain in optimizing the delivery, specificity, and safety of these therapeutics. While the field of cancer epigenetics has advanced significantly, several gaps remain:
(1) Lack of Large-Scale Clinical Trials: Most findings are preclinical; large trials are needed to validate clinical utility.
(2) Epigenetic Plasticity: Tumors can adapt to epigenetic therapies, leading to resistance.
(3) Integration with Multi-Omics: Combining epigenomic data with transcriptomics and proteomics may enhance precision in diagnosis and treatment.
In conclusion, this review highlights the central role of epigenetic alterations in hepatocellular carcinoma, encompassing DNA methylation, histone modifications, and noncoding RNAs. These mechanisms not only contribute to the initiation and progression of HCC but also represent promising avenues for diagnostic, prognostic, and therapeutic development. As our understanding of the epigenetic landscape deepens, translating these insights into clinical practice could pave the way for more precise and effective interventions in HCC management.
See the article:
Bueloni B, Garcia Fernandez de Barrena M, Avila MA, et al. Epigenetic mechanisms involved in hepatocellular carcinoma development and progression. eGastroenterology 2025;3:e100186. doi:10.1136/ egastro-2025-100186
About eGastroenterology
eGastroenterology is a new, open-access, and open peer-reviewed BMJ Journal, which focuses on basic, clinical, translational, and evidence-based medicine research in all areas of gastroenterology (including hepatology, pancreatology, esophagology, and gastrointestinal surgery). eGastroenterology is now indexed by PubMed, Scopus, CAS, DOAJ, Dimensions, OpenAlex, ROAD, and COPE, with more to come!
For more information, please visit: egastroenterology.bmj.com and follow us on Twitter (@eGastro_BMJ).
Sign-up to Email Alerts for eGastroenterology: https://emails.bmj.com/k/Bmj/jausu/egastroenterology
END
NEW YORK, NY— June 18, 2025 —The American Thoracic Society Research Program has announced that four researchers have been awarded early-career grants to support research advancing pulmonary, critical care, and sleep medicine. The grants, which are generously sponsored by Johnson & Johnson, total $400,000.
These awards support early-career investigators conducting research aimed at understanding the pathways and pathophysiology of pulmonary vascular disease.
The following researchers ...
Researchers from Florida Atlantic University’s Charles E. Schmidt College of Medicine have received a $1 million grant from the Florida Medical Malpractice Joint Underwriting Association to launch a new initiative: the Geriatric Emergency Department Pharmacologic Harm Prevention Project (GREAT PHARM). This program seeks to reduce falls and other adverse drug events (ADEs) among older adults by using pharmacogenomic-guided prescribing, a personalized approach that tailors medications to an individual’s genetic profile.
As America’s population ...
Inflammatory Bowel Disease (IBD), encompassing ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic inflammatory condition of the gastrointestinal tract with a rising global burden. Traditional diagnostic methods like endoscopy are invasive and costly, underscoring the need for non-invasive biomarkers. Recent research highlights the gut microbiome's pivotal role in IBD pathogenesis, alongside metabolomic and immunological dysregulation. This review synthesizes current knowledge on these biomarkers, proposing an integrative model ...
Astronomers have created a galactic masterpiece: an ultra-detailed image that reveals previously unseen features in the Sculptor Galaxy. Using the European Southern Observatory’s Very Large Telescope (ESO’s VLT), they observed this nearby galaxy in thousands of colours simultaneously. By capturing vast amounts of data at every single location, they created a galaxy-wide snapshot of the lives of stars within Sculptor.
"Galaxies are incredibly complex systems that we are still struggling to understand," says ESO researcher Enrico Congiu, who led a new Astronomy & Astrophysics study on Sculptor. Reaching ...
Most treatments for Parkinson’s disease (PD) only slow disease progression. Early intervention for the neurological disease that worsens over time is therefore critical to optimize care, but that requires early diagnosis. Current tests, like clinical rating scales and neural imaging, can be subjective and costly. Now, researchers in ACS’ Analytical Chemistry report the initial development of a system that inexpensively screens for PD from the odors in a person’s ear wax.
Previous research has ...
COLUMBUS, Ohio – The personal credit scores of top-level corporate executives can help explain their decision making in the corporate environment, at least when it involves evaluating risk, a new study suggests.
Researchers at The Ohio State University conducted an experiment with a national sample of high-level executives and found that those with subprime credit scores tended to be “yes persons” – even when it was counterproductive.
In contrast, executives with prime ...
Humans have tens of thousands of genes, many of which produce proteins essential to basic bodily functions. The KCNT1 gene, for example, codes for a protein that maintains normal electrical activity in the brain and helps neurons communicate.
But genes don’t always function perfectly.
For many people, a mutation of the KCNT1 gene causes no symptoms. For others, it can lead to dysfunction of neuronal activity causing learning disabilities, difficulty communicating, and a lifetime of treatment-resistant seizures.
Epileptic disorders caused by mutations in KCNT1 affect ...
LA JOLLA (June 18, 2025)—Salk Assistant Professor Deepshika Ramanan has been named a Rita Allen Foundation Scholar, a distinction given to early-career leaders in the biomedical sciences whose research holds exceptional promise for revealing new pathways to advance human health.
"Shika’s exceptional talent, determination, collaborative spirit, and mentorship skills make her a very deserving recipient of this award,” says Salk President Gerald Joyce. “Her bold approach to important but underappreciated topics in immunology is likely ...
In a unique collaboration between the University of Groningen and the Carl von Ossietzky Universität Oldenburg, researchers studied population trends across 3,058 populations of various species throughout the entire Wadden Sea. Twenty-four per cent of the populations showed a significant decline in size, and this trend is occurring simultaneously across various groups. Only fourteen per cent of the populations showed an increase in size. These findings were published in the journal Global Change Biology on June ...
Birmingham-based Fallouh Healthcare has been awarded a grant of £305,050 from Innovate UK as part of the Eureka Eurostar programme to finalise a prototype of PerDeCT™, working alongside their Austrian partner the Medizinische Universität Wien, which aims to be the first device for monitoring cardiac function and early diagnosis of cardiac tamponade, a life-threatening complication after heart surgery.
Although cardiac surgery is safe, cardiac tamponade can come on quickly – usually after the patient has left theatre, and typically late at night when the patient is in intensive care.
It is caused by the accumulation ...
